{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:04:27Z","timestamp":1785301467232,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,28]]},"DOI":"10.7759\/cureus.113551","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:53:11Z","timestamp":1785300791000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Adenosine Deaminase (ADA) and Mycobacterial Growth Indicator Tube (MGIT): The Utility of Xpert MTB\/RIF Ultra for Diagnosis and Resistance Determination in Suspected Tubercular Pleural Effusion in a High-Burden State"],"prefix":"10.7759","author":[{"given":"Tanya","family":".","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankana","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadeep","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Global tuberculosis report 2025. (2025). Accessed. June 5, 2026: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.03.021","article-title":"The rapid molecular test Xpert MTB\/RIF Ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection","volume":"25","author":"Opota O","year":"2019","unstructured":"Opota O, Mazza-Stalder J, Greub G, Jaton K. The rapid molecular test Xpert MTB\/RIF Ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect. 2019, 25:1370-6. 10.1016\/j.cmi.2019.03.021","journal-title":"Clin Microbiol Infect"},{"key":"ref3","unstructured":"WHO meeting report of a technical expert consultation. non-inferiority analysis of Xpert MTB\/RIF Ultra compared to Xpert MTB\/RIF. (2017). Accessed: June 5, 2026: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2017.04."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05727-8","article-title":"The transition to Xpert MTB\/RIF Ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda","volume":"21","author":"Andama A","year":"2021","unstructured":"Andama A, Jaganath D, Crowder R, et al.. The transition to Xpert MTB\/RIF Ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda. BMC Infect Dis. 2021, 21:49. 10.1186\/s12879-020-05727-8","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093148","article-title":"Xpert MTB\/RIF Ultra trace results: decision support for the treatment of extrapulmonary tuberculosis in low TB burden countries","volume":"12","author":"Guillouzouic A","year":"2023","unstructured":"Guillouzouic A, Gaudart A, Tessier E, et al.. Xpert MTB\/RIF Ultra trace results: decision support for the treatment of extrapulmonary tuberculosis in low TB burden countries. J Clin Med. 2023, 12:3148. 10.3390\/jcm12093148","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2024.101730","article-title":"Diagnostic accuracy of Xpert MTB\/RIF and Xpert Ultra tests in pulmonary and extrapulmonary tuberculosis compared to L\u00f6wenstein-Jensen culture","volume":"29","author":"Hueda-Zavaleta M","year":"2024","unstructured":"Hueda-Zavaleta M, Gomez-de-la-Torre J, Barletta-Carrillo C, et al.. Diagnostic accuracy of Xpert MTB\/RIF and Xpert Ultra tests in pulmonary and extrapulmonary tuberculosis compared to L\u00f6wenstein-Jensen culture. Clin Epidemiol Glob Health. 2024, 29:101730. 10.1016\/j.cegh.2024.101730","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268483","article-title":"Xpert MTB\/RIF Ultra versus Xpert MTB\/RIF for diagnosis of tuberculous pleural effusion: a systematic review and comparative meta-analysis","volume":"17","author":"Aggarwal AN","year":"2022","unstructured":"Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Xpert MTB\/RIF Ultra versus Xpert MTB\/RIF for diagnosis of tuberculous pleural effusion: a systematic review and comparative meta-analysis. PLoS One. 2022, 17:e0268483. 10.1371\/journal.pone.0268483","journal-title":"PLoS One"},{"key":"ref8","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. module 3: diagnosis. (2025). Accessed: June 5, 2026: https:\/\/www.who.int\/publications\/i\/item\/9789240107984."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515039-beyond-adenosine-deaminase-ada-and-mycobacterial-growth-indicator-tube-mgit-the-utility-of-xpert-mtbrif-ultra-for-diagnosis-and-resistance-determination-in-suspected-tubercular-pleural-effusion-in-a-high-burden-state","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:53:33Z","timestamp":1785300813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515039-beyond-adenosine-deaminase-ada-and-mycobacterial-growth-indicator-tube-mgit-the-utility-of-xpert-mtbrif-ultra-for-diagnosis-and-resistance-determination-in-suspected-tubercular-pleural-effusion-in-a-high-burden-state"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.113551","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}